Scientists at YTÜ have developed an active pharmaceutical ingredient to combat cervical cancer
Researchers at Yıldız Technical University have developed a new active pharmaceutical ingredient that successfully destroys cervical cancer cells in a laboratory setting. Animal testing will soon begin for the compound, which was synthesized with the goal of reducing the severe side effects of chemotherapy and has been granted an international patent.